Advanced

Guidelines for radioiodine therapy of differentiated thyroid cancer

Luster, M.; Clarke, S. E.; Dietlein, M.; Lassmann, M.; Lind, P.; Oyen, W. J. G.; Tennvall, Jan LU and Bombardieri, E. (2008) In European Journal of Nuclear Medicine and Molecular Imaging 35(10). p.1941-1959
Abstract
Introduction The purpose of the present guidelines on the radioiodine therapy (RAIT) of differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear Medicine (EANM) Therapy Committee is to provide advice to nuclear medicine clinicians and other members of the DTC-treating community on how to ablate thyroid remnant or treat inoperable advanced DTC or both employing large 131-iodine (I-131) activities. Discussion For this purpose, recommendations have been formulated based on recent literature and expert opinion regarding the rationale, indications and contraindications for these procedures, as well as the radioiodine activities and the administration and patient preparation techniques to be used. Recommendations... (More)
Introduction The purpose of the present guidelines on the radioiodine therapy (RAIT) of differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear Medicine (EANM) Therapy Committee is to provide advice to nuclear medicine clinicians and other members of the DTC-treating community on how to ablate thyroid remnant or treat inoperable advanced DTC or both employing large 131-iodine (I-131) activities. Discussion For this purpose, recommendations have been formulated based on recent literature and expert opinion regarding the rationale, indications and contraindications for these procedures, as well as the radioiodine activities and the administration and patient preparation techniques to be used. Recommendations also are provided on pre-RAIT history and examinations, patient counselling and precautions that should be associated with I-131 iodine ablation and treatment. Furthermore, potential side effects of radioiodine therapy and alternate or additional treatments to this modality are reviewed. Appendices furnish information on dosimetry and post-therapy scintigraphy. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
radioiodine treatment, radioiodine therapy, thyroid remnant ablation, guidelines
in
European Journal of Nuclear Medicine and Molecular Imaging
volume
35
issue
10
pages
1941 - 1959
publisher
Springer
external identifiers
  • wos:000259413600024
  • scopus:52449123946
ISSN
1619-7070
DOI
10.1007/s00259-008-0883-1
language
English
LU publication?
yes
id
7e2cc2cf-8b7a-4b29-8411-2b77eb29a0b7 (old id 1287307)
date added to LUP
2009-01-22 12:31:05
date last changed
2017-11-19 03:31:31
@article{7e2cc2cf-8b7a-4b29-8411-2b77eb29a0b7,
  abstract     = {Introduction The purpose of the present guidelines on the radioiodine therapy (RAIT) of differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear Medicine (EANM) Therapy Committee is to provide advice to nuclear medicine clinicians and other members of the DTC-treating community on how to ablate thyroid remnant or treat inoperable advanced DTC or both employing large 131-iodine (I-131) activities. Discussion For this purpose, recommendations have been formulated based on recent literature and expert opinion regarding the rationale, indications and contraindications for these procedures, as well as the radioiodine activities and the administration and patient preparation techniques to be used. Recommendations also are provided on pre-RAIT history and examinations, patient counselling and precautions that should be associated with I-131 iodine ablation and treatment. Furthermore, potential side effects of radioiodine therapy and alternate or additional treatments to this modality are reviewed. Appendices furnish information on dosimetry and post-therapy scintigraphy.},
  author       = {Luster, M. and Clarke, S. E. and Dietlein, M. and Lassmann, M. and Lind, P. and Oyen, W. J. G. and Tennvall, Jan and Bombardieri, E.},
  issn         = {1619-7070},
  keyword      = {radioiodine treatment,radioiodine therapy,thyroid remnant ablation,guidelines},
  language     = {eng},
  number       = {10},
  pages        = {1941--1959},
  publisher    = {Springer},
  series       = {European Journal of Nuclear Medicine and Molecular Imaging},
  title        = {Guidelines for radioiodine therapy of differentiated thyroid cancer},
  url          = {http://dx.doi.org/10.1007/s00259-008-0883-1},
  volume       = {35},
  year         = {2008},
}